Endoscopy 2012; 44(12): 1165-1167
DOI: 10.1055/s-0032-1325674
Case report/series
© Georg Thieme Verlag KG Stuttgart · New York

Macroscopic and histologic regression of duodenal polyposis with FOLFOX4 chemotherapy for an ileal pouch adenocarcinoma in a patient with familial adenomatous polyposis

M. Pioche
1   Gastroenterology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
G. Aguero Garcete
1   Gastroenterology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
J. Forestier
2   Digestive Oncology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
V. Lépilliez
1   Gastroenterology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
C. Nozières
2   Digestive Oncology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
C. Lombard-Bohas
2   Digestive Oncology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
,
J.-C. Saurin
1   Gastroenterology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 04. Juli 2012

accepted after revision 26. Juli 2012

Publikationsdatum:
27. November 2012 (online)

Preview

Severe (stage IV) duodenal polyposis is difficult to manage in patients with familial adenomatous polyposis (FAP), with no effective medical treatment, complex endoscopic treatment modalities, and a high morbidity and mortality from pancreaticoduodenectomy. We present the case of a 44-year-old woman with FAP, stage IV duodenal polyposis, and with an ileal pouch adenocarcinoma that required surgery and adjuvant chemotherapy. Her duodenal polyposis regressed to stage II after four sessions of FOLFOX4 adjuvant chemotherapy, which avoided the need for aggressive endoscopic therapy or pancreatoduodenectomy in this patient.